Narrow your search by using the search box and/or filters to the left.
A recent study of cystic fibrosis (CF) infants and toddlers, conducted by a multinational team of researchers including several from the Center for Cystic Fibrosis and Airways Disease Research (CF-AIR), has revealed potential metabolite biomarkers for monitoring and evaluating risk of lung disease in early life CF.
“Early life elevations of methionine oxidation and ornithine track and predict cystic fibrosis structural lung disease" was published in European Respiratory Journal Open Research on March 25, 2025, with Joshua Chandler, PhD, an Emory University Assistant Professor and the incoming Scientific Director of the Pediatric Metabolomics and Biomarkers Core (PMBC), as the corresponding author.
Center for Cystic Fibrosis and Airways Disease Research (CF-AIR)
Raymond Schinazi, PhD, Frank Amblard, PhD, and Leda Bassit, PhD were awarded Start-Up of the Year on April 17, 2025, at the 40 year-celebration ceremony of the Emory University Office of Technology Transfer for their start-up, Aligos Therapeutics. Aligos Therapeutics is a clinical-stage biotechnology company founded with the mission to improve patient outcomes by developing best-in-class therapies.
Center for ViroScience and Cure (CVC)
Atlanta’s Marcus Autism Center is studying root causes of elopement, or running away from supervision, among children with autism — and what caretakers can do to make wandering less likely. Marcus Autism Center conducted the largest study yet of the risks of elopement, or wandering, among children with autism and what caretakers can do to mitigate those risks. Click here for the GPB article and interview with the study's first author, Mindy Scheithauer, PhD, BCBA-D. Link to this study can be found here.
Marcus Autism Center
The cores administrative team is thrilled to announce that the Biomarkers Core will re-launch as the Pediatric Metabolomics and Biomarkers Core. Under Dr. Joshua Chandler's leadership, the PMBC will offer multiple new services, including polytargeted metabolomics, isotope tracing, and high-resolution MS imaging. The new core and services are expected to begin operating in summer 2025.
We are pleased to announce that 44 members of the Emory University School of Medicine Department of Pediatrics were honored as part of the 2025 National Doctors' Day Recognition; 20 of these honorees are Center members of the Children’s + Emory Pediatric Research Alliance. These Emory faculty members were nominated by their peers and colleagues for their dedication to improving the health and well-being of our patients and community through the care they provide, the research they conduct and their efforts to teach and inspire learners.
We congratulate each of these doctors on this recognition, celebrate their accomplishments, and thank them for their continued stellar contributions to our community!
Link here for more information and the complete listing of all honorees.
Seven members of the Emory faculty have been named by the American Association for the Advancement of Science (AAAS) as 2024 Fellows. The AAAS selects fellows for their outstanding efforts in the advancement of science based on research, teaching, administration and technology, as well as communicating and interpreting science to the public. Emory’s new fellows join a distinguished list of previous fellows including Thomas Edison, W. E. B. DuBois, retired astronaut Ellen Ochoa and former Secretary of Energy Steven Chu.
Emory faculty selected as 2024 AAAS Fellows include Tené T. Lewis, Edmund K. Waller, Anant Madabhushi, Ilya Nemenman, Wilbur Lam, Li Xiong and David H. Lawson. They will receive the AAAS gold and blue rosette pin (representing science and engineering, respectively) to commemorate their election and be celebrated at a D.C. forum in June.
Aflac Cancer and Blood Disorders Center (Aflac)
Marcus Center for Cellular Therapy
Pediatric Technology Center (PTC)
Research and Epidemiology for Adolescent and Child Health (REACH) Center
A small but powerful invention could make life in the NICU easier for the tiniest patients.
Newborns must have their vitals checked frequently, and one of the most critical measures of newborn health is electrolyte levels. Right now, the only way to monitor electrolytes is to draw their blood multiple times a day. This can be painful and frightening for babies, and challenging to perform for medical staff, who can have trouble drawing blood from tiny, underdeveloped blood vessels.
Now, researchers at the Georgia Institute of Technology have developed a pacifier designed to monitor a baby’s electrolyte levels in real time, potentially eliminating the need for repeated invasive blood draws.
Hong Yeo, associate professor and Harris Saunders Jr. Endowed Professor in the George W. Woodruff School of Mechanical Engineering, came up with the pacifier idea at a pediatric technology conference. Doctors described daily challenges they face in caring for sick newborns, and the lack of noninvasive monitoring systems.
Click here to read the full story.
Pediatric Technology Center (PTC)
Emory + Children’s Announce Launch of the Research and Epidemiology for Adolescent and Child Health (REACH) Center
Emory and Children’s have launched the Research and Epidemiology for Adolescent and Child Health (REACH) Center. Led by newly recruited distinguished faculty members, Philip Lupo, PhD and Michael Scheurer, PhD, and in partnership with the former Center for Clinical Research and Public Health (CORPH) Interim Director, Shasha Bai, PhD, REACH is designed to serve as a leading hub for child-focused and population-based research and aims to advance collaborative research initiatives to improve pediatric health outcomes.
REACH builds upon the work of the Center for CORPH, which was founded in 2011 by Dr. Ann Mertens to support child health-focused clinical outcomes and public health research. CORPH has played a crucial role in promoting high-quality epidemiologic and clinical research, mentoring young investigators, and linking healthcare practices to patient outcomes to improve quality of care. The work of CORPH was transformative and has led to this important next phase.
Research and Epidemiology for Adolescent and Child Health (REACH) Center
This 40-page report highlights the incredible accomplishments of Children's-Emory researchers in 2024 and shares our vision for research moving forward.
National Institutes for Health (NIH) funding is critical to ensure academic medical centers continue to pursue innovative research in areas that advance patient care and human health. As a leading R1 research institute, Emory University is forging new pathways to advance science and clinical care through this essential federal funding.
Each year, the Blue Ridge Institute for Medical Research (BRIMR) publishes a ranking of U.S. academic institutions and health care systems based on the research funding they received from NIH the prior year.
In 2024, Emory received more than $488 million and is among the top 20 in the nation overall for institutional funding from the NIH.
